Related Experiment Video
Updated: Feb 17, 2026
05:10
Multidisciplinary Approach to Obesity Management: A Case Report
Published on: May 30, 2025
1.3K
Controlling Chronic Diseases Through Evidence-Based Decision Making: A Group-Randomized Trial.
Ross C Brownson1,2, Peg Allen3, Rebekah R Jacob3
1Prevention Research Center in St. Louis, Brown School, Washington University in St. Louis, One Brookings Dr, Campus Box 1196, St. Louis, MO 63130.
Preventing Chronic Disease
|December 2, 2017
Summary
State health departments can improve evidence-based decision making through tailored training. This study found improved skills and access to evidence after capacity-building interventions, enhancing public health practice.
Area of Science:
- Public Health
- Health Services Research
- Implementation Science
Background:
- State health departments are crucial for implementing evidence-based interventions.
- Limited research exists on building practitioner capacity for evidence-based decision-making (EBDM).
- Capacity building is needed at both individual and organizational levels.
Purpose of the Study:
- To explore methods for increasing EBDM at individual and organizational levels within state health departments.
- To evaluate the impact of a capacity-building intervention on EBDM skills and organizational practices.
Main Methods:
- A 2-arm, group-randomized trial involving 12 state health departments.
- Intervention group received multiday EBDM training and supplemental capacity-building activities.
- Individual skills and organizational outcomes (access to evidence, participatory decision-making) were assessed 18-24 months post-training.
Main Results:
- Intervention group showed significant improvement in overall EBDM skill gap (P=.01).
- Six specific EBDM skill areas improved significantly in the intervention group.
- Organizational outcomes showed improved access to evidence and skilled staff (P=.04).
Conclusions:
- Tailored, active strategies are effective for building individual and organizational capacity in EBDM.
- Dissemination interventions can enhance public health practice.
- Findings offer practical approaches for leaders aiming to improve evidence utilization.
Related Concept Videos
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
488
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
488
01:16Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
01:12Hazard Ratio
638
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
638
01:26Atherosclerosis III: Management
460
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
460
01:11Blinding
4.0K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.0K
01:15Methods of Documentation VI: Case Management Model
966
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
966